Delivery Order SPE2DR25D3103-SPE2DR26F9P74
- Not listed
- The Defense Logistics Agency awarded a $4,939.58 firm fixed-price delivery order to AmerisourceBergen Drug Corp on November 28, 2025, for the supply of Tezspire 210 mg/1.91 mL pen injectors. The contract, which carries no set-aside designation, represents a competitively awarded transaction under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. Performance will be completed by December 19, 2025, at...
- The Defense Logistics Agency has awarded a delivery order valued at $4,939.58 to AmerisourceBergen Drug Corp for the supply of Tezspire 210 mg/1.91 mL pen injectors. This is a firm fixed price, competitively awarded contract with an ultimate completion date of November 28, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child delivery order under a larger contract vehicle, this award leverages AmerisourceBergen's...
- The Defense Logistics Agency awarded a $4,687.18 delivery order to AmerisourceBergen Drug Corp on June 10, 2025, for the supply of Tezspire 210 mg/1.91 mL pen injectors. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The products will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a $18,748.72 delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Tezspire 210 mg/1.91 mL pen injectors, with performance completion by September 30, 2025. This non-competitive delivery order utilizes firm fixed pricing and represents a child contract under AmerisourceBergen's larger federal contracting vehicle with DLA. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 18, 2025, for the supply of Tezspire 210 mg/1.91 mL pen injections, with a ceiling value of $4,939.58 and ultimate completion by December 10, 2025. This firm fixed-price delivery order is being performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, and represents a non-set-aside competitive award. The delivery order is issued under AmerisourceBergen's broader Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $4,939.58 to AmerisourceBergen Drug Corp on December 15, 2025, for the supply of Tezspire 210 mg/1.91 mL pen injectors, with completion scheduled for January 7, 2026. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $4,939.58 to AmerisourceBergen Drug Corp on October 31, 2025, for the supply of Tezspire 210 mg/1.91 ml pen injectors, with an ultimate completion date of November 24, 2025. This firm fixed price, competitively awarded delivery order (with no set-aside designation) is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $4,939.58 firm fixed price delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Tezspire 210 mg/1.91 mL pen injectors, with performance to be completed by December 1, 2025. This non-set-aside competitive award is being fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Tezspire 210 mg/1.91 ml pen injectors, valued at $2,343.59, with an ultimate completion date of September 16, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to federal medical procurement needs. The contract is performed from the company's corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of Tezspire 210 mg/1.91 ml pen injectors, valued at $2,469.78 with a completion date of December 29, 2025. This firm fixed price delivery order was competitively awarded without set-aside provisions and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December...
- SPE2DR25D3103Indefinite Delivery Contract
- SPE2DR25D3103-SPE2DR26F9P74Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,939.58 to AmerisourceBergen Drug Corp for Tezspire 210 mg/1.91 mL pen injectors on December 16, 2025, with an ultimate completion date of January 8, 2026. This firm fixed-price contract represents a non-competitive set-aside delivery against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, will perform this delivery from its corporate office location in the same city. This delivery order exemplifies AmerisourceBergen's critical role as a prime vendor in the federal medical supply chain, supplying specialty pharmaceutical products to support military and veteran healthcare systems. Tezspire is a biologic medication used in respiratory disease management, reflecting the company's portfolio that encompasses specialty medications, brand-name drugs, vaccines, and medical devices across multiple therapeutic domains. As a child delivery order under the comprehensive SPE2DX prime vendor agreement, this contract demonstrates the flexibility and scalability of AmerisourceBergen's relationship with DLA to meet dynamic federal healthcare procurement requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.9k | 12/15/25 |